First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
NCT07362888
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors (Phase 1)
Interventions
DRUG:
ADCE-B05
Sponsor
Adcendo ApS